Blog
RSS FeedPosted by Michael Wonder on 16 Oct 2015
Can measuring anticoagulant activity and concentration in the body play a role in clinical use of medicines used to prevent blood clots?
16 October 2015 - The European Medicines Agency is calling for expressions of interest from experts and stakeholders to attend a ...
Posted by Michael Wonder on 13 Oct 2015
Collecting high-quality information on medicines through patient registries
12 October 2015 - The European Medicines Agency (EMA) has launched an initiative on patient registries aimed at making better use ...
Posted by Michael Wonder on 06 Oct 2015
EMA Management Board: highlights of October 2015 meeting
6 October 2015 - The Management Board heard an update on the European Medicines Agency’s (EMA) activities in the first half ...
Posted by Michael Wonder on 01 Oct 2015
European Medicines Agency’s Management Board nominates Guido Rasi as Executive Director
1 October 2015 - The European Medicines Agency’s (EMA’s) Management Board has nominated Professor Guido Rasi as the Executive Director of ...
Posted by Michael Wonder on 29 Sep 2015
Management Board expected to nominate EMA Executive Director on 1 October 2015
29 September 2015 - The European Medicines Agency’s (EMA) Management Board will meet on Thursday 1 October for an extraordinary session. ...
Posted by Michael Wonder on 28 Sep 2015
New guidance to speed up development of antibiotics
28 September 2015 - The European Medicines Agency (EMA) has released a draft guideline for public consultation on the use of ...
Posted by Michael Wonder on 26 Sep 2015
EMA fast-tracks antidote to anticoagulant Pradaxa
25 September 2015 - The European Medicines Agency (EMA) has recommended granting a marketing authorisation, following accelerated assessment, for Praxbind (idarucizumab) ...
Posted by Michael Wonder on 26 Sep 2015
New medicine to treat heart failure recommended for approval
25 September 2015 - The European Medicines Agency (EMA) has recommended granting a marketing authorisation for Entresto (sacubitril with valsartan) for ...
Posted by Michael Wonder on 26 Sep 2015
New treatment option for patients with rare blood cancer
25 September 2015 - The European Medicines Agency (EMA) has recommended granting a marketing authorisation for Kyprolis (carfilzomib) to treat patients ...
Posted by Michael Wonder on 25 Sep 2015
EU marketing approval granted for VivaGel BV
24 September 2015 - Starpharma today announced it has received, overnight, marketing approval in the European Union (EU) for VivaGel BV ...
Posted by Michael Wonder on 22 Sep 2015
EMA update on publication of clinical data
22 September 2015 - The European Medicines Agency (EMA) has published today the presentations and summaries of the discussions held at ...
Posted by Michael Wonder on 21 Sep 2015
CHMP Chair re-elected
21 September 2015 - The Committee for Medicinal Products for Human Use (CHMP) re-elected Dr Tomas Salmonson as its Chair at ...
Posted by Michael Wonder on 14 Sep 2015
Janssen submits marketing authorisation application for daratumumab for European patients with heavily pre-treated multiple myeloma
9 September 2015 - Janssen-Cilag International NV announced today it has submitted a new marketing authorisation application to the European Medicines ...
Posted by Michael Wonder on 11 Sep 2015
Merck intends to submit cladribine tablets to treat multiple sclerosis for registration in Europe
11 September 2015 -Merck, a leading company for innovative and top-quality high-tech products in healthcare, life science and performance materials ...
Posted by Michael Wonder on 07 Sep 2015
Demonstrating significant benefit of orphan medicines
4 September 2015 - The European Medicines Agency (EMA) is organising a workshop on 7 December 2015 to discuss the approach ...